-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENTALIS PHARMACEUTICALS ANNOUNCES FIRST OVERALL SURVIVAL DATA FOR AZENOSERTIB FROM DENALI PART 1B PUBLISHED IN ESMO CONGRESS 2026 ABSTRACT

Reuters·10/18/2026 22:07:59

Please log in to view news